banner add

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

from NYT > Health https://ift.tt/HO1FV4S
via IFTTT

No comments

The Organ Transplant List Is Being Ignored

Organ transplant waiting lists are designed to fairly distribute organs to the sickest patients in order of priority. Or so we thought. A Ne...

Theme images by PLAINVIEW. Powered by Blogger.